Esperion Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q2 2013 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Esperion Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2013 to Q3 2024.
  • Esperion Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 1, 2024 was 197M shares, a 73.3% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 197M +83.3M +73.3% Nov 1, 2024 10-Q 2024-11-07
Q2 2024 196M +89.2M +83.4% Aug 1, 2024 10-Q 2024-08-12
Q1 2024 189M +94.7M +100% May 1, 2024 10-Q 2024-05-07
Q3 2023 114M +40M +54.3% Nov 1, 2023 10-Q 2023-11-07
Q2 2023 107M +40.4M +60.8% Jul 28, 2023 10-Q 2023-08-01
Q1 2023 94.7M +31.7M +50.3% May 1, 2023 10-Q 2023-05-09
Q4 2022 76.6M +13.8M +21.9% Feb 1, 2023 10-K 2023-02-21
Q3 2022 73.7M +44.6M +153% Oct 31, 2022 10-Q 2022-11-01
Q2 2022 66.6M +38.3M +135% Aug 1, 2022 10-Q 2022-08-02
Q1 2022 63M +34.8M +123% May 1, 2022 10-Q 2022-05-03
Q4 2021 62.8M +34.9M +125% Feb 1, 2022 10-K 2022-02-22
Q3 2021 29.1M +1.2M +4.31% Nov 1, 2021 10-Q 2021-11-02
Q2 2021 28.3M +452K +1.63% Aug 1, 2021 10-Q 2021-08-03
Q1 2021 28.2M +575K +2.08% May 1, 2021 10-Q 2021-05-04
Q4 2020 27.9M +430K +1.56% Feb 1, 2021 10-K 2021-02-23
Q3 2020 27.9M +549K +2.01% Nov 1, 2020 10-Q 2020-11-02
Q2 2020 27.8M +655K +2.41% Aug 1, 2020 10-Q 2020-08-10
Q1 2020 27.6M +700K +2.6% May 1, 2020 10-Q 2020-05-06
Q4 2019 27.5M +688K +2.56% Feb 1, 2020 10-K 2020-02-27
Q3 2019 27.3M +516K +1.93% Nov 1, 2019 10-Q 2019-11-06
Q2 2019 27.2M +367K +1.37% Aug 1, 2019 10-Q 2019-08-08
Q1 2019 26.9M +132K +0.49% May 1, 2019 10-Q 2019-05-08
Q4 2018 26.8M +326K +1.23% Feb 1, 2019 10-K 2019-02-28
Q3 2018 26.8M +613K +2.34% Oct 31, 2018 10-Q 2018-11-01
Q2 2018 26.8M +4.21M +18.6% Aug 1, 2018 10-Q 2018-08-02
Q1 2018 26.8M +4.2M +18.6% May 1, 2018 10-Q 2018-05-02
Q4 2017 26.5M +3.94M +17.5% Feb 1, 2018 10-K 2018-02-20
Q3 2017 26.2M +3.64M +16.2% Nov 1, 2017 10-Q 2017-11-07
Q2 2017 22.6M +42.7K +0.19% Aug 1, 2017 10-Q 2017-08-08
Q1 2017 22.6M +49K +0.22% May 1, 2017 10-Q 2017-05-04
Q4 2016 22.6M +14.9K +0.07% Feb 1, 2017 10-K 2017-02-22
Q3 2016 22.6M +34.9K +0.16% Nov 1, 2016 10-Q 2016-11-03
Q2 2016 22.6M +61.7K +0.27% Aug 1, 2016 10-Q 2016-08-04
Q1 2016 22.5M +2.12M +10.4% May 1, 2016 10-Q 2016-05-04
Q4 2015 22.5M Feb 1, 2016 10-K 2016-02-25
Q3 2015 22.5M +2.17M +10.7% Nov 1, 2015 10-Q 2015-11-05
Q2 2015 22.5M +7.04M +45.6% Aug 1, 2015 10-Q 2015-08-06
Q1 2015 20.4M +5.03M +32.7% Mar 1, 2015 10-K 2015-03-10
Q3 2014 20.3M +4.99M +32.5% Nov 1, 2014 10-Q 2014-11-10
Q2 2014 15.4M +87.6K +0.57% Aug 1, 2014 10-Q 2014-08-12
Q1 2014 15.4M Mar 1, 2014 10-K 2014-03-13
Q3 2013 15.4M Nov 1, 2013 10-Q 2013-11-06
Q2 2013 15.4M Aug 1, 2013 10-Q 2013-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.